FDA approves PARP inhibitor for ovarian cancer

Months ahead of schedule, the US Food and Drug Administration approved…

Para acessar a publicação na íntegra clique  aqui

Fonte: 398 VOLUME 35 NUMBER 5 MAY 2017 NATURE BIOTECHNOLOGY